CDK4/6 inhibitors: A Changing Paradigm

Day 1, Wednesday 7th November 2018

13:30- 17:00 CDK4/6 inhibitors: A Changing Paradigm
Moderators Dr. Dahish Ajarim and Dr. Omalkhair Abulkhair
15:30-16:00 “The Growing role of CDK4/6 inhibitors in treating hormone receptor-positive advanced breast cancer-The biology background”
Keynote Speaker: Prof. Jean-Marc A. Nabholtz, MD, PhD;
King Saud University Medical City, Riyadh, Saudi Arabia
16:00-16:20 “Molecular mechanisms of endocrine resistance: The clinic impact”
Speaker: Dr. Taher Al-Tweigeri, MD, MBBch, FRCPC; KFSH&RC, Riyadh, Saudi Arabia
16:20-16:40 “Present Revolution and Future Evolution of the management of luminal breast cancer”
Speaker: Dr. Ahmed Saad Eddin, MD, FRCR (UK); King Abdulaziz Medical City, Riyadh, Saudi Arabia
16:40-17:00 Zahra BC Association
19:30-22:00 Social Event

Speakers

Prof. Jean-Marc A. Nabholtz, MD, PhD

Lecture Title: "The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer-The Biology Background"

Dr. Taher Tweigeri, MBBch, FRCPC

Lecture Title: "Molecular Mechanisms of Endocrine Resistance: The Clinic Impact"


Ahmed Ali Saadeddin, MD, FRCR (UK)

Lecture Title: "A Future Evolution in the Management of Luminal breast Cancer"